Love DermNet?

Subscribe to our monthly newsletter.

PEComa pathology

Author: Assoc Prof Patrick Emanuel, Dermatopathologist, Auckland, New Zealand, 2013.

PEComas are a group of mesenchymal tumours composed of perivascular epithelioid cells. This family of tumours includes a spectrum of neoplasms in different organs including angiomyolipoma of the kidney and liver, sugar tumour of the lung, lymphangiomatosis, and lymphangiomyoma.

Histology of PEComa

Sections show a discrete mass in the dermis (figure 1). The tumour is composed of epithelioid cells with clear to eosinophilic cytoplasm and round to oval nuclei with obvious nucleoli (figure 2-3). They frequently exhibit a nested or trabecular arrangement (figure 3).

Malignant PEComas are reported but are exceedingly rare in the skin. Worrisome features are said to include large tumour size, infiltrative growth pattern, high nuclear grade, necrosis, mitotic activity, marked pleomorphism and nuclear atypia.

Special studies for PEComa

Periodic acid-Shif (PAS) and PAS-Diastase stains showed glycogen deposition within the cytoplasm of the clear cells of PEComa.

Immunohistochemistry reveals HMB-45 is strongly positive in all cases. Microftalmia associated transcription factor (MiTF) and desmin may show some staining. S-100 is negative.

Differential diagnosis of PEComa pathology

Given the rarity of this PEComa, immunohistochemical studies are generally needed to distinguish this tumour from other tumours which also exhibit clear cells. These are listed below. HMB-45 positivity and S100 negativity in a clear cell tumour should raise the possibility of PEComa.

Other clear cell tumours in the differential diagnosis:

Related information

Make a donation

Donate Today

Help us to update and maintain DermNet New Zealand

Submit your images

We are expanding our image library

Contact us

Skin lesion photography

Watch Dr Amanda Oakley presenting "Skin lesion photography" at The Australasian Skin Cancer Congress.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter